Massachusetts H4123 mandates distribution of opioid antagonists to incarcerated individuals upon release from correctional facilities.

Massachusetts H4123 requires any correctional facility, county correctional facility, state prison, jail, or house of correction to provide two doses of opioid antagonists to an incarcerated individual upon their release. The distribution must be conducted by a department-approved pharmacist or their designee. Opioid antagonists include naloxone or any other drug approved by the FDA as a competitive narcotic antagonist used in the reversal of opioid overdoses. This measure aims to address the risk of opioid overdose among recently released individuals.

Massachusetts H4123 mandates distribution of opioid antagonists to incarcerated individuals upon release from correctional facilities.

Massachusetts H4123 requires any correctional facility, county correctional facility, state prison, jail, or house of correction to provide two doses of opioid antagonists to an incarcerated individual upon their release. The distribution must be conducted by a department-approved pharmacist or their designee. Opioid antagonists include naloxone or any other drug approved by the FDA as a competitive narcotic antagonist used in the reversal of opioid overdoses. This measure aims to address the risk of opioid overdose among recently released individuals.